Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.36% |
| 2 | Financials | 9.66% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Energy | 7.72% |
| 5 | Technology | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1026
Ford
F
$48.2B
| $9.83M | 0.02% |
582,775
+419,669
| +257% | +$7.09M |
2013 Q2
1 quarter
|
|
1027
CALL
Colgate-Palmolive
CL
$67.3B
| $9.8M | 0.01% |
165,300
-59,100
| -26% | -$3.5M |
2013 Q2
1 quarter
|
|
|
SIVB
1028
DELISTED
SVB Financial Group
SIVB
| $9.79M | 0.01% |
113,285
+107,733
| +1,940% | +$9.31M |
2013 Q2
1 quarter
|
|
|
NRF
1029
DELISTED
NorthStar Realty Finance Corp.
NRF
| $9.78M | 0.01% |
536,866
-225,583
| -30% | -$4.11M |
2013 Q2
1 quarter
|
|
|
EMC
1030
CALL
DELISTED
EMC CORPORATION
EMC
| $9.78M | 0.01% |
382,700
-177,300
| -32% | -$4.6M |
2013 Q2
1 quarter
|
|
|
LLL
1031
DELISTED
L3 Technologies, Inc.
LLL
| $9.77M | 0.01% |
103,379
-25,705
| -20% | -$2.37M |
2013 Q2
1 quarter
|
|
|
AGN
1032
PUT
DELISTED
Allergan Inc
AGN
| $9.77M | 0.01% |
108,000
-10,400
| -9% | -$934K |
2013 Q2
1 quarter
|
|
|
SPN
1033
DELISTED
Superior Energy Services, Inc.
SPN
| $9.76M | 0.01% |
38,980
+11,843
| +44% | +$3.08M |
2013 Q2
1 quarter
|
|
1034
CALL
Pultegroup
PHM
$22B
| $9.76M | 0.01% |
591,200
+220,000
| +59% | +$3.75M |
2013 Q2
1 quarter
|
|
|
SEMG
1035
DELISTED
SEMGROUP CORPORATION
SEMG
| $9.75M | 0.01% |
+171,007
| New | +$9.48M |
2013 Q3
0 quarters
|
|
|
TYC
1036
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $9.75M | 0.01% |
266,226
-2,867,331
| -92% | -$104M |
2013 Q2
1 quarter
|
|
1037
CALL
Perrigo
PRGO
$2B
| $9.75M | 0.01% |
79,000
+47,000
| +147% | +$5.87M |
2013 Q2
1 quarter
|
|
|
JCP
1038
DELISTED
J.C. Penney Company, Inc.
JCP
| $9.75M | 0.01% |
1,105,042
+540,301
| +96% | +$7.71M |
2013 Q2
1 quarter
|
|
|
TMH
1039
DELISTED
Team Health Holdings Inc
TMH
| $9.74M | 0.01% |
256,724
+94,298
| +58% | +$3.7M |
2013 Q2
1 quarter
|
|
|
STJ
1040
DELISTED
St Jude Medical
STJ
| $9.7M | 0.01% |
180,774
+174,245
| +2,669% | +$8.97M |
2013 Q2
1 quarter
|
|
1041
Upbound Group
UPBD
$943M
| $9.69M | 0.01% |
254,362
+96,180
| +61% | +$3.71M |
2013 Q2
1 quarter
|
|
1042
Portland General Electric
POR
$5.22B
| $9.65M | 0.01% |
341,718
+291,957
| +587% | +$8.72M |
2013 Q2
1 quarter
|
|
|
BBBY
1043
CALL
DELISTED
Bed Bath & Beyond Inc
BBBY
| $9.59M | 0.01% |
124,000
-2,800
| -2% | -$210K |
2013 Q2
1 quarter
|
|
1044
PUT
Macy's
M
$5.92B
| $9.57M | 0.01% |
221,200
+33,700
| +18% | +$1.57M |
2013 Q2
1 quarter
|
|
1045
Hyatt Hotels
H
$15B
| $9.55M | 0.01% |
222,344
-221,055
| -50% | -$9.7M |
2013 Q2
1 quarter
|
|
|
GLBR
1046
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
| $9.54M | 0.01% |
48,317
-42,664
| -47% | -$7.68M |
2013 Q2
1 quarter
|
|
|
PACD
1047
DELISTED
Pacific Drilling S A
PACD
| $9.51M | 0.01% |
85,856
+13,846
| +19% | +$1.38M |
2013 Q2
1 quarter
|
|
1048
Flex
FLEX
$43.2B
| $9.51M | 0.01% |
1,388,408
-1,215,305
| -47% | -$8M |
2013 Q2
1 quarter
|
|
1049
Edwards Lifesciences
EW
$49.3B
| $9.49M | 0.01% |
817,848
+768,852
| +1,569% | +$8.99M |
2013 Q2
1 quarter
|
|
1050
HF Sinclair
DINO
$20.2B
| $9.47M | 0.01% |
224,972
-605,449
| -73% | -$26.3M |
2013 Q2
1 quarter
|
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors withdrew a net $4.68B in Q3 2013, closing 505 positions and reducing 3,074 holdings. Its most notable exit was NEWS CORPORATION CL-A, an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 41% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in ELAN CORP ADS(RP1 ORD4IRISH PN worth $100M.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 734 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.